Nivolumab and ipilimumab combination treatment in advanced intrahepatic cholangiocarcinoma and gallbladder cancer

Klein, O; Carlino, M; Brown, M; Harris, SJ; Gunjur, A; Underhill, CR; Zielinski, R; Kee, D; Lam, W-S; Chan, H; Harrup, RA; So, J; Collins, I; Michael, M; Torres, J; Palmer, JB; Thomas, D; Wilkie, K; Cebon, J; Nagrial, A

Nivolumab and ipilimumab combination treatment in advanced intrahepatic cholangiocarcinoma and gallbladder cancer

journal contribution

posted on 2025-09-11, 05:38 authored by O Klein, M Carlino, M Brown, SJ Harris, A Gunjur, CR Underhill, R Zielinski, D Kee, W-S Lam, H Chan, RA Harrup, J So, I Collins, M Michael, J Torres, JB Palmer, D Thomas, K Wilkie, J Cebon, A Nagrial

Nivolumab and ipilimumab combination treatment in advanced intrahepatic cholangiocarcinoma and gallbladder cancer

Funding

Bristol Myers Squibb Ltd.; Omico; Minderoo Foundation; Medical Research Future Fund Australia.

History

Related Materials

1.
DOI - Is version of https://doi.org/10.1016/j.annonc.2024.05.288

Location

GERMANY, Munich

Language

English

Journal

ANNALS OF ONCOLOGY

Volume

35

Pagination

S119-S119

ISSN

0923-7534

eISSN

1569-8041

Publisher

ELSEVIER

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Oncology

Nivolumab and ipilimumab combination treatment in advanced intrahepatic cholangiocarcinoma and gallbladder cancer

Funding

Bristol Myers Squibb Ltd.; Omico; Minderoo Foundation; Medical Research Future Fund Australia.

History

Related Materials

Location

Language

Journal

Volume

Pagination

ISSN

eISSN

Publisher

Usage metrics

Categories

Keywords

Licence

Exports